Delivery Order SPE2DB20D1004-SPE2DB25FNFWE

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The award, valued at $6,502.20, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,784.60, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a completion date of May 5, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,812.19. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the procurement of Epinephrine 0.3 mg auto-injectors. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,836.08 and runs through February 18, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of epinephrine 0.15 mg auto-injectors. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,732.22 and was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. This contract is a delivery order against a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
The federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $11,099.01, was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is a Firm Fixed Price delivery order with a completion date of September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Epinephrine 0.15 mg Auto-Injectors to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $6,713.46 and an ultimate completion date of May 22, 2024. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products to the Defense Logistics Agency (DLA). The $5,218.24 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 20, 2025, with a completion date of March 21, 2025. The contract is a delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the supply of epinephrine 0.15 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $2,386.10. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors (2-pack) to the Defense Logistics Agency (DLA). The $3,101.14 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 12, 2024 and was awarded on July 11, 2024. This delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNFWE
    Delivery Order

This federal contract award is for the delivery of EPINEPHRINE 0.15 MG AUTO-INJECTORS to the Defense Logistics Agency (DLA). The contract, valued at $2,289.66, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 26, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/24/25, 10:05 AM